Site Highlights Product Features and Resources for Compliance with
CDC and OSHA Regulations
LIMERICK, Pa., Oct 04, 2011 (BUSINESS WIRE) --
The Arrow(R) ErgoPack(TM) System is a human factors research-based vascular
access insertion system designed to provide defense against known
sources of bloodstream infection. Teleflex(R) recently launched a new
website to highlight the features and benefits of this system, which is
designed to help healthcare institutions attain and sustain the goal of
zero Central Line-Associated Blood Stream Infections (CLABSIs) while
reducing procedure times and allowing for more efficient insertions.
The website offers:
-
Detailed explanation of the ErgoPack System, including video examples
showing use of the system.
-
Supporting detail outlining the System's approach to meeting 2011 CDC
guidelines for protecting staff and patients, as well as OSHA and
Sharps safety as directed under the Needlestick Safety and Prevention
Act.
-
Instructions for use and full explanations of the antimicrobial
catheter technology, including ARROWg+ard Blue PLUS(R) and Chlorag+ard(TM)
technology, which provide defense against all five sources of
bloodstream infection.
-
Additional information, such as a free vascular access insertion
poster, access card and ErgoPack white paper.
The site is specifically targeted to provide information for healthcare
providers and infection control professionals. Healthcare institutions
across the United States have been encouraged to develop protocols and
processes to help reduce the rates of preventable hospital acquired
infections. Many hospitals have started initiatives to drive down their
CLABSI rate, driven by patient safety concerns and in direct response to
the Centers for Medicare and Medicaid's (CMS) 2008 announcement that it
would no longer reimburse for Serious Reportable Events, or "Never
Events," for Medicare as of October 1, 2008 and for all Medicaid
patients in 2012. The site and the ErgoPack System are designed to
address the issue of "Never Events" and respond to requirements for
mandatory public reporting of Hospital Acquired Infections (HAIs),
specifically CLABSIs. Teleflex is committed to supplying technology and
tools to help hospitals attain and sustain the goal of zero CLABSIs.
To learn more about the Arrow ErgoPack System and how it can play a role
in meeting current and anticipated guidelines, visit arrowergopack.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,600 people worldwide and serves
healthcare providers in more than 130 countries. Additional information
about Teleflex can be obtained from the company's website at http://www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President Investor Relations
610-948-2836